Free Trial

Safe Pro Group Inc. Common Stock (SPAI) Competitors

Safe Pro Group Inc. Common Stock logo
$2.85 -0.09 (-3.06%)
Closing price 04:00 PM Eastern
Extended Trading
$2.93 +0.08 (+2.84%)
As of 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SPAI vs. CATX, SKIN, PDEX, TLSI, OBIO, STIM, SGHT, ZJYL, KRMD, and MGRM

Should you be buying Safe Pro Group Inc. Common Stock stock or one of its competitors? The main competitors of Safe Pro Group Inc. Common Stock include Perspective Therapeutics (CATX), Beauty Health (SKIN), Pro-Dex (PDEX), TriSalus Life Sciences (TLSI), Orchestra BioMed (OBIO), Neuronetics (STIM), Sight Sciences (SGHT), Jin Medical International (ZJYL), KORU Medical Systems (KRMD), and Monogram Orthopaedics (MGRM). These companies are all part of the "medical equipment" industry.

Safe Pro Group Inc. Common Stock vs.

Perspective Therapeutics (NYSE:CATX) and Safe Pro Group Inc. Common Stock (NASDAQ:SPAI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Perspective Therapeutics presently has a consensus target price of $14.56, indicating a potential upside of 489.29%. Given Perspective Therapeutics' stronger consensus rating and higher possible upside, equities analysts plainly believe Perspective Therapeutics is more favorable than Safe Pro Group Inc. Common Stock.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Perspective Therapeutics
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
3 Strong Buy rating(s)
3.17
Safe Pro Group Inc. Common Stock
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Safe Pro Group Inc. Common Stock has a net margin of 0.00% compared to Perspective Therapeutics' net margin of -4,096.66%. Safe Pro Group Inc. Common Stock's return on equity of 0.00% beat Perspective Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Perspective Therapeutics-4,096.66% -27.40% -23.16%
Safe Pro Group Inc. Common Stock N/A N/A N/A

In the previous week, Perspective Therapeutics had 9 more articles in the media than Safe Pro Group Inc. Common Stock. MarketBeat recorded 11 mentions for Perspective Therapeutics and 2 mentions for Safe Pro Group Inc. Common Stock. Safe Pro Group Inc. Common Stock's average media sentiment score of 0.95 beat Perspective Therapeutics' score of -0.11 indicating that Safe Pro Group Inc. Common Stock is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Perspective Therapeutics
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Safe Pro Group Inc. Common Stock
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Perspective Therapeutics received 29 more outperform votes than Safe Pro Group Inc. Common Stock when rated by MarketBeat users.

CompanyUnderperformOutperform
Perspective TherapeuticsOutperform Votes
29
96.67%
Underperform Votes
1
3.33%
Safe Pro Group Inc. Common StockN/AN/A

54.7% of Perspective Therapeutics shares are held by institutional investors. 3.5% of Perspective Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Safe Pro Group Inc. Common Stock has higher revenue and earnings than Perspective Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Perspective Therapeutics$1.43M116.74-$46.51MN/AN/A
Safe Pro Group Inc. Common Stock$1.56M25.15N/AN/AN/A

Summary

Perspective Therapeutics beats Safe Pro Group Inc. Common Stock on 9 of the 14 factors compared between the two stocks.

Remove Ads
Get Safe Pro Group Inc. Common Stock News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPAI vs. The Competition

MetricSafe Pro Group Inc. Common StockSurgical appliances & supplies IndustryBusiness SectorNASDAQ Exchange
Market Cap$39.21M$9.14B$7.56B$8.30B
Dividend YieldN/A1.41%2.52%4.02%
P/E RatioN/A17.6830.9019.25
Price / Sales25.1570.05150.3894.10
Price / CashN/A19.6731.5134.64
Price / BookN/A5.655.024.46
Net IncomeN/A$284.66M$194.85M$247.07M
7 Day Performance-5.32%2.33%1.71%3.05%
1 Month Performance-20.17%-1.93%-2.71%-2.85%
1 Year PerformanceN/A-15.84%6.80%4.63%

Safe Pro Group Inc. Common Stock Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPAI
Safe Pro Group Inc. Common Stock
N/A$2.85
-3.1%
N/AN/A$39.21M$1.56M0.0011Gap Up
CATX
Perspective Therapeutics
2.9548 of 5 stars
$2.60
+0.4%
$14.56
+459.8%
N/A$175.73M$1.43M0.0070Upcoming Earnings
SKIN
Beauty Health
1.5694 of 5 stars
$1.32
flat
$2.50
+89.4%
-67.1%$163.84M$334.29M-3.141,030
PDEX
Pro-Dex
1.9233 of 5 stars
$48.89
-1.6%
$52.00
+6.4%
+187.5%$159.43M$61.00M24.32140
TLSI
TriSalus Life Sciences
3.2617 of 5 stars
$5.15
-2.1%
$11.56
+124.5%
-42.0%$157.04M$26.89M-2.07106Upcoming Earnings
News Coverage
Positive News
Gap Down
High Trading Volume
OBIO
Orchestra BioMed
1.7126 of 5 stars
$4.11
+0.7%
$16.25
+295.4%
-13.1%$156.24M$2.65M-2.554Upcoming Earnings
STIM
Neuronetics
2.4407 of 5 stars
$5.06
+11.9%
$5.50
+8.7%
+10.4%$153.56M$74.89M-4.11180
SGHT
Sight Sciences
3.1921 of 5 stars
$2.78
+2.2%
$3.83
+37.9%
-40.3%$142.71M$79.87M-2.73210
ZJYL
Jin Medical International
N/A$0.89
+4.4%
N/A-76.4%$139.14M$23.50M0.00245News Coverage
Positive News
Gap Down
KRMD
KORU Medical Systems
2.1658 of 5 stars
$2.97
+7.2%
$4.70
+58.2%
+34.3%$136.14M$33.65M-11.8880
MGRM
Monogram Orthopaedics
3.2092 of 5 stars
$3.67
+57.5%
$4.00
+9.0%
+26.2%$129.51M$364,999.00-7.8128High Trading Volume
Remove Ads

Related Companies and Tools


This page (NASDAQ:SPAI) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners